The Beauty Health Company (SKIN) Reports Q1 Revenues of $47.5M; Offers FY21 Revenues Outlook

Go back to The Beauty Health Company (SKIN) Reports Q1 Revenues of $47.5M; Offers FY21 Revenues Outlook

The Beauty Health Company (SKIN) PT Raised to $16 at DA Davidson

May 14, 2021 8:51 AM EDT

DA Davidson analyst Linda Bolton Weiser raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $16.00 (from $15.50) while maintaining a Buy rating.

The analyst commented, "Vesper Healthcare (VSPR) successfully de-SPACed (redemption rate of... More